无菌性翻修全膝关节置换术后的患者报告结局指标(疼痛、功能与生活质量)
前瞻性队列研究纳入246例2016年1月至2017年12月接受无菌性翻修全膝关节置换术(rTKA)且有基线与术后1年患者报告结局指标(PROMs)的患者,评估疼痛、功能、生活质量与整体健康的改善及预测因素。术后1年KOOS疼痛、功能简表(PS)与生活质量(QOL)平均分别改善30.3分、19.15分与29.7分,但54.9%的患者VR-12躯体成分汇总(PCS)无临床改善,仅31.3%的患者VR-12精神成分汇总(MCS)有改善。
要点
- 无菌性rTKA术后1年KOOS疼痛、PS与QOL平均分别改善30.3分、19.15分与29.7分。
- 54.9%的患者VR-12 PCS无临床改善,仅31.3%的患者VR-12 MCS有改善。
- KOOS疼痛改善与高龄、基线关节纤维化、较低基线疼痛及非Medicare/Medicaid保险相关。
核心结论
- 总体而言,接受无菌性rTKA的患者在术后1年疼痛、功能与生活质量PROMs均有改善。
- 尽管总体生活质量改善,其他整体健康PROMs保持不变。
- 本研究强调的关联可帮助在无菌性rTKA术前设定预期,从而指导术前临床决策过程。
研究设计与样本
- 前瞻性队列研究,纳入2016年1月至2017年12月接受无菌性rTKA且有基线与术后1年PROMs的246例患者。
- 最常见手术指征为无菌性松动(n=109)、不稳(n=73)与假体失败(n=64)。
- 采用患者嵌套于外科医生的多水平模型分析PROMs预测因素。
主要发现
- 整体rTKA系列术后1年KOOS疼痛与PS平均分别改善30.3分与19.15分。
- KOOS疼痛改善与高龄、基线关节纤维化、较低基线疼痛及非Medicare/Medicaid保险相关,评分恶化与多次既往手术及不稳相关。
- KOOS-PS改善与基线关节纤维化及女性性别相关,恶化与基线功能受限、不稳诊断、多次既往手术及住院时间(LOS)增加相关。
- 整体KOOS-QOL平均改善29.7分;VR-12 PCS平均改善,但54.9%的患者无临床改善;仅31.3%的患者VR-12 MCS有改善。
- 多水平混合效应模型显示外科医生间结果差异极小,分别仅解释KOOS疼痛、KOOS-PS与KOOS-QOL未被其他预测因素解释方差的约1.86%、约1.12%与约1.65%。
临床怎么用
- 作者认为本研究的关联可帮助在无菌性rTKA术前设定预期,从而指导术前临床决策过程。
局限性
- 证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the growing frequency of revision total knee arthroplasty (rTKA), there is limited information regarding patient-reported outcome measures (PROMs) after that procedure. Therefore, the purpose of this study was to determine (1) PROM improvements in pain, function, quality of life (QOL), and global health and (2) predictors of PROMs for patients undergoing aseptic rTKA as determined using a multilevel model with patients nested within surgeons. METHODS: A prospective cohort of 246 patients who underwent aseptic rTKA from January 2016 to December 2017 and had baseline and 1-year postoperative PROMs were analyzed. The most common surgical indications were aseptic loosening (n = 109), instability (n = 73), and implant failure (n = 64). The PROMs included in this study were the Knee injury and Osteoarthritis Outcome Score (KOOS)-Pain, -Physical Function Short Form (PS), and -Quality of Life (QOL) as well as the Veterans Rand-12 (VR-12) Physical Component Summary (PCS) and Mental Component Summary (MCS). Multivariable linear regression models with patients nested within surgeons were constructed for predicting change in PROMs from baseline to 1 year. RESULTS: The mean 1-year postoperative improvements in the KOOS-Pain and PS PROMs were 30.3 and 19.15 points, respectively, for the overall rTKA series. Improvement in the KOOS-Pain was associated with older age, baseline arthrofibrosis, lower baseline pain, and non-Medicare/Medicaid insurance and worsening of the scores was associated with multiple prior surgical procedures and instability. Improvement in the KOOS-PS was associated with baseline arthrofibrosis and female sex and worsening was associated with limited baseline function, an instability diagnosis, multiple prior surgical procedures, and increased hospital length of stay (LOS). Overall, the mean KOOS-QOL improved by 29.7 points. Although the mean VR-12 PCS improved, 54.9% of the patients saw no clinical improvement. Additionally, only 31.3% of the patients reported improvements in the VR-12 MCS. A multilevel mixed-effects model with patients/operations nested within surgeons demonstrated that the differences in the surgeons' results were minimal and explained only ∼1.86%, ∼1.12%, and ∼1.65% of the KOOS-Pain, KOOS-PS, and KOOS-QOL variance that was not explained by other predictors, respectively. CONCLUSIONS: Overall, patients undergoing aseptic rTKA had improvements in pain, function, and QOL PROMs at 1 year. Although overall QOL improved, other global-health PROMs remained unchanged. The associations highlighted in this study can help guide the preoperative clinical decision-making process by setting expectations before aseptic rTKA. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Piuzzi NS. Patient-Reported Outcome Measures (Pain, Function, and Quality of Life) After Aseptic Revision Total Knee Arthroplasty. J Bone Joint Surg Am. 2020. PMID: 33086349. doi:10.2106/JBJS.19.01155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。